Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni M Brand

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|January 14, 2011
Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrateToni M Brand, Deric L Wheeler
Small Gtpases|June 21, 2012
KRAS mutant colorectal tumors: past and presentToni M Brand, Deric L Wheeler
Cancer Biology & Therapy|February 5, 2011
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximabToni M Brand, Mari Iida, Deric L Wheeler
Discovery Medicine|December 1, 2011
The nuclear epidermal growth factor receptor signaling network and its role in cancerToni M Brand, Mari Iida, Chunrong Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2018
Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77]Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
Nuclear EGFR as a molecular target in cancerToni M Brand, Mari Iida, Neha Luthar, et al.
Plos One|August 17, 2013
Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3Toni M Brand, Mari Iida, Neha Luthar, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|January 14, 2011
Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrateToni M Brand, Deric L Wheeler
Small Gtpases|June 21, 2012
KRAS mutant colorectal tumors: past and presentToni M Brand, Deric L Wheeler
Cancer Biology & Therapy|February 5, 2011
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximabToni M Brand, Mari Iida, Deric L Wheeler
Discovery Medicine|December 1, 2011
The nuclear epidermal growth factor receptor signaling network and its role in cancerToni M Brand, Mari Iida, Chunrong Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2018
Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77]Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
Nuclear EGFR as a molecular target in cancerToni M Brand, Mari Iida, Neha Luthar, et al.
Plos One|August 17, 2013
Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3Toni M Brand, Mari Iida, Neha Luthar, et al.
Cancer Biology & Therapy|June 14, 2013
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximabMari Iida, Toni M Brand, David A Campbell, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Seminars in Cell & Developmental Biology|January 26, 2016
Adaptive responses to antibody based therapyTamara S Rodems, Mari Iida, Toni M Brand, et al.
Pageof 4